Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.
Reads0
Chats0
TLDR
The depth of invasion was studied using the criteria for staging of Clark et al.2 to see if maximal cross-sectional area, thickness, stage of invasion, or a combination of these can be of value in assessing the prognosis of cutaneous melanoma.Abstract:
CuTANEous melanoma is a most unpredictable lesion. The marked variation in prognosis is probably a function of many variables, one of which is the size of the tumor. Though there is a roughly inverse relationship between the diameter of the lesion and survival,5 very small lesions have recurred or metastasized. One possible reason for the lack of reliability of tumor size in estimating prognosis may be that studies to date have considered size in only two diamensions and have neglected tumor volume. Two melanomas can have the same diameter but differ greatly in thickness because of variation in either depth of invasion or degree of protrusion from the surface of the skin or both. A recent study 2 has shown that prognosis correlates well with staging of the depth of invasion, but there have been no studies relating survival to tumor volume. To measure tumor volume it is necessary to know the surface area of the tumor, but in this retrospective study we only know the maximal diameters of the lesions. By measuring the maximal thickness of the lesions we can calculate the maximal crosssectional area, which should be roughly proportional to the volume of the tumor. The depth of invasion was also studied using the criteria for staging of Clark et al.2 to see if maximal cross-sectional area, thickness, stage of invasion, or a combination of these can be of value in assessing the prognosis of cutaneous melanoma. A total of 98 lesions were so studied.read more
Citations
More filters
Journal ArticleDOI
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
R O Pritchard-Jones,D B A Dunn,Yan Qiu,Alexander H. R. Varey,Antonio Orlando,H Rigby,Steve J Harper,D. O. Bates +7 more
TL;DR: Results suggest that there is a switch in splicing as part of the metastatic process, from anti-angiogenic to pro-Angiogenic VEGF isoforms, which may form part of a wider metastatic splicing phenotype.
Journal ArticleDOI
Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features.
TL;DR: The Swedish National Cancer Registry opened its records to the authors for review of all 219 females with primary vulvar melanoma reported from 1960 to 1984 as mentioned in this paper, and the 198 patients who qualified for this study were reanalyzed and the tumors rigorously subtyped.
Journal ArticleDOI
Visual Screening for Malignant Melanoma: A Cost-effectiveness Analysis
Elena Losina,Rochelle P. Walensky,Alan C. Geller,Frederick C. Beddingfield,Lindsey L. Wolf,Barbara A. Gilchrest,Kenneth A. Freedberg +6 more
TL;DR: One-time melanoma screening of the general population older than 50 years is very cost-effective compared with other cancer screening programs in the United States.
Journal ArticleDOI
Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas
TL;DR: It is shown that osteonectin expression is a predictor of clinical outcome in thin cutaneous melanomas and no significant correlation was found between osteonECTin expression and other clinicopathologic features, including age, sex, site, histotype, Clark's level, presence of regression, and tumor growth phase.
Journal ArticleDOI
HLA-DR Antigen Expression in Primary Melanomas of the Skin
TL;DR: Ninety-three primary malignant melanomas of the skin were typed immunohistologically for the expression of HLA-DR on tumor cells and the majority of tumors that had metastasized within an observation period of 0-32 months were Hla-DR-positive.
References
More filters
Journal ArticleDOI
Some Methods for Strengthening the Common χ 2 Tests
TL;DR: In this article, the authors discuss two kinds of failure to make the best use of x2 tests which I have observed from time to time in reading reports of biological research, and propose a number of methods for strengthening or supplementing the most common uses of the ordinary x2 test.
Journal Article
The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin
TL;DR: Evidence is presented suggesting that superficial spreading melanoma and lentigo maligna melanoma (Hutchinson9s melanotic freckle) show a long period of superficial growth, followed by the relatively rapid appearance of nodules or deeper invasion within the primary lesion.
Journal ArticleDOI
The Detection of Partial Association, I: The 2 × 2 Case
TL;DR: In this article, a criterion for testing null hypotheses of conditional independence of two dichotomous random variables is derived for testing whether the association of the two random variables in the conditional distribution is, in a certain sense, constant.
Journal ArticleDOI
Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults.
Related Papers (5)
The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Charles M. Balch,Antonio C. Buzaid,Seng Jaw Soong,Michael B. Atkins,Natale Cascinelli,Daniel G. Coit,Irvin D. Fleming,Jeffrey E. Gershenwald,Alan Houghton,John M. Kirkwood,Kelly M. McMasters,Martin F. Mihm,Donald L. Morton,Douglas S. Reintgen,M. I. Ross,Arthur J. Sober,John A. Thompson,John F. Thompson +17 more
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch,Jeffrey E. Gershenwald,Seng-Jaw Soong,John F. Thompson,Michael B. Atkins,David R. Byrd,Antonio C. Buzaid,Alistair J. Cochran,Daniel G. Coit,Shouluan Ding,Alexander M.M. Eggermont,Keith T. Flaherty,Phyllis A. Gimotty,John M. Kirkwood,Kelly M. McMasters,Martin C. Mihm,Donald L. Morton,Merrick I. Ross,Arthur J. Sober,Vernon K. Sondak +19 more
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Charles M. Balch,Seng Jaw Soong,Jeffrey E. Gershenwald,John F. Thompson,Douglas S. Reintgen,Natale Cascinelli,Marshall M. Urist,Kelly M. McMasters,M. I. Ross,John M. Kirkwood,Michael B. Atkins,John A. Thompson,Daniel G. Coit,David R. Byrd,Renee A. Desmond,Yuting Zhang,Ping-Yu Liu,Gary H. Lyman,Aberto Morabito +18 more